Alembic Pharma Gets EIR From USFDA For Gujarat API Unit

Alembic Pharmaceuticals Ltd. on Wednesday said it has received an Establishment Inspection Report from the US Food and Drug Administration for its active pharmaceutical ingredient-III facility in Karakhadi, Gujarat.

The US regulator had inspected the facility between March 17 and March 21 and concluded the process without issuing any observations, the company said in an exchange filing.